High rate of complete remisions (CR) with concomitant chemoradiotherapy (QRT) in esophageal cancer (EC).: Preliminary results in a phase II trial.

被引：0
|
作者：
Balmana, J
Brunet, J
Balart, J
Rodriguez, MR
Montesinos, J
Rius, X
Gallen, M
Arcusa, A
Pardo, B
Marcuello, E
López, JJL
机构：
[1] Hosp St Pau, Med Oncol Serv, Barcelona, Spain
[2] Hosp St Pau, Serv Radioterapia, Barcelona, Spain
[3] Hosp St Pau, Serv Cirugia, Barcelona, Spain
[4] Hosp Del Mar, Serv Oncol, Barcelona, Spain
[5] Gen Hosp, Terrassa, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S75 / S75
页数：1
相关论文
共 50 条
  • [1] Phase III randomized trial of definitive chemoradiotherapy (CRT) with FOLFOX or cisplatin and fluorouracil in esophageal cancer (EC): Final results of the PRODIGE 5/ACCORD 17 trial.
    Conroy, Thierry
    Galais, Marie-Pierre
    Raoul, Jean Luc
    Bouche, Olivier
    Gourgou-Bourgade, Sophie
    Douillard, Jean-Yves
    Etienne, Pierre-Luc
    Boige, Valerie
    Martel-Lafay, Isabelle
    Michel, Pierre
    Llacer-Moscardo, Carmen
    Berille, Jocelyne
    Bedenne, Laurent
    Adenis, Antoine
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] Preoperative chemoradiation and cetuximab for resectable, locally advanced esophageal cancer: Preliminary results of a prospective phase Ib/II trial.
    Brenner, Baruch
    Kundel, Yulia
    Purim, Ofer
    Medalia, Gal
    Olshinka, Liran
    Kashtan, Hanoch
    Menasherov, Nikolai
    Fenig, Eyal
    Sulkes, Aaron
    Idelevich, Efraim
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] Chemoradiotherapy in high-risk prostate cancer (QRT SOGUG trial): Preliminary report
    Foro Arnalot, P.
    Maldonado, X.
    Bonet, M.
    Jove, J.
    Rovirosa, A.
    Rico, M.
    Bejar, A.
    Sancho, G.
    Vega, M. J.
    Mira, M.
    Martinez, M.
    Algara, M.
    Carles, J.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S157 - S157
  • [4] Phase II trial of perioperative chemotherapy of esophageal cancer: PIECE trial.
    Nomura, Motoo
    Goto, Masahiro
    Watanabe, Masayuki
    Hato, Shinji
    Kato, Ken
    Baba, Eishi
    Matsubara, Hisahiro
    Mukaida, Hidenori
    Yoshii, Takako
    Tsuda, Masahiro
    Tsubosa, Yasuhiro
    Kitagawa, Yuko
    Hideki, Ishikawa
    Muto, Manabu
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [5] A phase II feasibility trial of neoadjuvant chemoradiotherapy combined with atezolizumab for resectable esophageal adenocarcinoma: The PERFECT trial.
    van den Ende, Tom
    de Clercq, Nicolien C.
    Henegouwen, Mark I. van Berge
    Gisbertz, Suzanne S.
    Meijer, Sybren L.
    Schokker, Sandor
    Bergman, Jacques J. G. H. M.
    Mohammad, Nadia Haj
    Ruurda, Jelle P.
    van Hillegersberg, Richard
    Mook, Stella
    Nieuwdorp, Max
    Soeratram, Tanya T. D.
    Ylstra, Bauke
    van Grieken, Nicole C. T.
    de Gruijl, Tanja D.
    Bijlsma, Maarten F.
    Hulshof, Maarten C. C. M.
    Van Laarhoven, Hanneke W. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [6] Adjuvant sunitinib (Su) for locally advanced esophageal cancer (LAEC): Results of a phase II trial.
    Knox, J. J.
    Wong, R.
    Darling, G. E.
    Lister, J.
    Guindi, M.
    Liu, G.
    Xu, W.
    Kim, J. J.
    Jonker, D. J.
    Wells, J.
    Kendal, W.
    Mackay, H.
    Visbal, A.
    Dinniwell, R. E.
    Pierre, A.
    Feld, R.
    Sundaresan, S.
    Bayley, A.
    Shargall, Y.
    Horgan, A. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] Complete 5-year follow-up of a prospective phase II trial of preoperative chemoradiotherapy for esophageal cancer
    Posner, MC
    Gooding, WE
    Lew, JI
    Rosenstein, MM
    Lembersky, BC
    SURGERY, 2001, 130 (04) : 620 - 626
  • [8] Triple induction chemotherapy and chemoradiotherapy in locally advanced esophageal cancer: Final results of a multicenter phase II trial
    Eisterer, W. M.
    De Vries, A.
    Spechtenhauser, B.
    Kendler, D.
    Koenigsrainer, A.
    Nehoda, H.
    Lukas, P.
    Woell, E.
    Oefner, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] Preoperative chemoradiotherapy for locally advanced rectal cancer: Multicenter phase II clinical trial.
    Hiratsuka, Takahiro
    Akagi, Tomonori
    Empuku, Shinichiro
    Nakajima, Kentaro
    Ueda, Yoshitake
    Tojigamori, Manabu
    Shiroshita, Hidefumi
    Etoh, Tsuyoshi
    Ninomiya, Shigeo
    Hiroishi, Kazuaki
    Yoshizumi, Fumitaka
    Takeuchi, Yu
    Sasaki, Atsushi
    Tahara, Koichiro
    Fujii, Kyuzo
    Shiromizu, Akio
    Ishikawa, Koichi
    Matsumoto, Toshifumi
    Bando, Toshio
    Inomata, Masafumi
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [10] COMPLETE RESPONSE (CR) TO NIMOTUZUMAB PLUS CHEMORADIATION IN LOCALLY ADVANCED ESOPHAGEAL CANCER: PRELIMINARY RESULTS OF AN ONGOING RANDOMIZED TRIAL
    Castro, G.
    Segalla, J.
    Stuemoller, C.
    Schmerling, R.
    Andrade, C. J.
    Pinczowski, H.
    Azevedo, S. J.
    Skare, N.
    Silva, C. R.
    Silva, I. D. C. G.
    ANNALS OF ONCOLOGY, 2010, 21 : 260 - 260
12345